MARTEK BIOSCIENCES CORP (MATK) [Rocket]

In millions, except per share items	Oct-31-10	Oct-31-09	Oct-31-08	Oct-31-07	Oct-31-06	Oct-31-05	Oct-31-04	Oct-31-03
	10-K	10-K	10-K	10-K	10-K	10-K	10-K/A	10-K/A
Revenues:
Nutritional ingredients	371.9	327.0	334.5
Branded consumer health products	61.4
Other	16.7	18.2	17.8
Total revenues [+]	450.0	345.2	352.4	306.8	270.7	217.9	184.5	114.7
Products	434.8	329.1	336.6
Services	15.3	16.1	15.8
Revenue growth [+]	30.4%	-2.0%	14.8%	13.4%	24.2%	18.1%	60.8%	149.1%
Nutritional ingredients	13.7%	-2.2%
Other	-8.0%	1.8%
Cost of goods sold [+]	233.3	196.6	206.8	193.3	173.3	133.4	115.0	66.3
Cost of product sales	220.4	182.4	192.8
Cost of services	12.9	14.3	14.0
Gross profit	216.8	148.6	145.5	113.5	97.4	84.5	69.5	48.4
Gross margin	48.2%	43.0%	41.3%	37.0%	36.0%	38.8%	37.7%	42.2%
Selling, general and administrative [+]	85.5	50.0	54.2	44.9	39.6	32.0	25.8	16.3
Sales and marketing	14.3	1.9	2.7
General and administrative	71.2	48.1	51.4
Research and development	33.6	27.4	26.2	24.9	24.0	19.4	18.6	13.2
Other operating expenses	12.0	7.5	8.9	8.2	4.0	10.1	4.0	4.1
EBITDA [+]	121.3	92.6	84.8	62.1	51.5	39.4	29.8	19.3
EBITDA growth	31.1%	9.1%	36.6%	20.6%	30.5%	32.4%	54.3%	-450.8%
EBITDA margin	27.0%	26.8%	24.1%	20.2%	19.0%	18.1%	16.1%	16.8%
Depreciation	25.1	22.6	21.2	19.9	18.9	14.0	8.7	4.5
EBITA	96.3	70.0	63.6	42.2	32.6	25.4	21.1	14.8
EBITA margin	21.4%	20.3%	18.1%	13.7%	12.0%	11.7%	11.4%	12.9%
Amortization of intangibles	10.5	6.4	7.4	6.6	2.8	2.5
EBIT [+]	85.8	63.6	56.2	35.6	29.8	22.9	21.1	14.8
EBIT growth	34.8%	13.2%	57.8%	19.6%	29.8%	8.7%	42.3%	-282.2%
EBIT margin	19.1%	18.4%	15.9%	11.6%	11.0%	10.5%	11.4%	12.9%
Non-recurring items	34.9			0.9	4.7			-0.3
Interest expense, net [+]	3.6	-0.4	-1.1
Interest expense	3.6	0.4	0.5
Interest income	0.0	0.8	1.6
Pre-tax income	47.3	64.0	57.3	33.7	23.5	24.1	21.9	16.0
Income taxes	19.4	23.5	19.7	1.7	8.6	8.8	-25.2	0.0
Tax rate	41.0%	36.6%	34.3%	4.9%	36.5%	36.5%		0.0%
Net income	27.9	40.6	37.7	32.0	0.0	0.0	0.0	0.0
Net margin	6.2%	11.8%	10.7%	10.4%	0.0%	0.0%	0.0%	0.0%

Basic EPS [+]	$0.84	$1.22	$1.14	$0.99	$0.00	$0.00	$0.00	$0.00
Growth	-31.7%	6.9%	15.5%	212729.9%	-5.2%	-69.7%	158.5%	-156.9%
Diluted EPS [+]	$0.83	$1.22	$1.13	$0.98	$0.00	$0.00	$0.00	$0.00
Growth	-31.7%	7.5%	15.2%	212562.1%	-3.2%	-69.2%	165.5%	-152.9%

Shares outstanding (basic) [+]	33.4	33.2	33.0	32.3	32.1	31.2	29.0	25.5
Growth	0.6%	0.8%	1.9%	0.7%	3.0%	7.3%	13.8%	16.1%
Shares outstanding (diluted) [+]	33.6	33.4	33.3	32.6	32.3	32.0	30.4	27.4
Growth	0.6%	0.2%	2.1%	0.8%	1.0%	5.4%	10.8%	24.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.